Clinical Trial

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Perform a comparison of effective pain relief duration between liposomal bupivacaine and dexmedetomidine when added to bupivacaine in a block for mastectomy for cancer surgery. The erector spinae plane block is a well-established block that is utilized for post operative pain control for procedures performed on the soft tissue of the chest and chest wall as well as intrathoracic procedures. The goal is comparison of the effective duration of both study groups to determine if there is a significant difference in time and amount of post operative opioids required which admitted to hospital.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-08; most recent amendment 2024-11-15.
Status change: Not Yet Recruiting → Recruiting 2024-11-15
Trial Details
NCT Number NCT06252662
Lead Sponsor United States Naval Medical Center, Portsmouth
Conditions Breast Cancer
Enrollment 200 participants
Start Date 2024-10-15
Primary Completion 2025-07 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2024-11-19